Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization

被引:52
作者
Itzhak, Y
Martin, JL
Black, MD
Ali, SF
机构
[1] Univ Miami, Sch Med, Dept Biochem & Mol Biol R62A, Miami, FL 33101 USA
[2] US FDA, Natl Ctr Toxicol Res, Div Neurotoxicol, Neurochem Lab, Jefferson, AR USA
关键词
methamphetamine; MPTP; melatonin; dopaminergic neurotoxicity; free radicals; locomotor activity; sensitization;
D O I
10.1016/S0028-3908(98)00067-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Methamphetamine (METH)- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity is thought to be associated with the formation of free radicals. Since evidence suggests that melatonin may act as a free radical scavenger and antioxidant, the present study was undertaken to investigate the effect of melatonin on METH- and MPTP-induced neurotoxicity. In addition, the effect of melatonin on METH-induced locomotor sensitization was investigated. The administration of METH (5 mg kg(-1) x 3) or MPTP (20 mg kg(-1) x 3) to Swiss Webster mice resulted in 45-57% depletion in the content of striatal dopamine and its metabolites, 3,4-dihydroxyphenylacetic acid and homovanillic acid, and 57-59% depletion in dopamine transporter binding sites. The administration of melatonin (10 mg kg(-1)) before each of the three injections of the neurotoxic agents (on day 1), and thereafter for two additional days, afforded a full protection against METH-ieduced depletion of dopamine and its metabolites and dopamine transporter binding sites. In addition, melatonin significantly diminished METH-induced hyperthermia. However, the treatment with melatonin had no significant effect on MPTP-induced depletion of the dopaminergic markers tested. In the set of behavioral experiments, we found that the administration of 1 mg kg(-1) METH to Swiss Webster mice for 5 days resulted in marked locomotor sensitization to a subsequent challenge injection of METH, as well as context-dependent sensitization (conditioning). The pretreatment with melatonin (10 mg kg(-1)) prevented neither the sensitized response to METH nor the development of conditioned locomotion. Results of the present study indicate that melatonin has a differential effect on the dopaminergic neurotoxicity produced by METH and MPTP. Since it is postulated that METH-induced hyperthermia is related to its neurotoxic effect, while regulation of body temperature is unrelated to MPTP-induced neurotoxicity or METH-induced locomotor sensitization, the protective effect of melatonin observed in the present study may be due primarily to diminishing METH-induced hyperthermia. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 50 条
[1]   Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice [J].
Itzhak, Y ;
Martin, JL ;
Ali, SF .
SYNAPSE, 1999, 34 (04) :305-312
[2]   1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity [J].
Kita, T ;
Saraya, T ;
Konishi, N ;
Matsunari, Y ;
Shimada, K ;
Nakamura, M ;
O'Hara, K ;
Wagner, GC ;
Nakashima, T .
PHARMACOLOGY & TOXICOLOGY, 2003, 92 (02) :71-80
[3]   Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity [J].
Mohanakumar, KP ;
Muralikrishnan, D ;
Thomas, B .
BRAIN RESEARCH, 2000, 864 (02) :281-290
[4]   Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice [J].
Muralikrishnan, D ;
Mohanakumar, KP .
FASEB JOURNAL, 1998, 12 (10) :905-912
[5]   Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity [J].
Dhanasekaran, Muralikrishnan ;
Albano, Christian B. ;
Pellet, Lori ;
Karuppagounder, Senthilkumar S. ;
Uthayathas, Subramaniam ;
Suppiramaniam, Vishnu ;
Brown-Borg, Holly ;
Ebadi, Manuchair .
NEUROCHEMICAL RESEARCH, 2008, 33 (06) :980-984
[6]   1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED NEUROTOXICITY IN THE RAT - CHARACTERIZATION AND AGE-DEPENDENT EFFECTS [J].
JARVIS, MF ;
WAGNER, GC .
SYNAPSE, 1990, 5 (02) :104-112
[7]   Acacetin Protects Dopaminergic Cells against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Neuroinflammation in Vitro and in Vivo [J].
Kim, Hyo Geun ;
Ju, Mi Sun ;
Ha, Sang Keun ;
Lee, Hyangsook ;
Lee, Hyejung ;
Kim, Sun Yeou ;
Oh, Myung Sook .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (08) :1287-1294
[8]   1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic denervation potentiates gabaergic inhibition in the mouse neostriatum in vitro [J].
Schlosser, B ;
Muller, A ;
Sutor, B ;
TenBruggencate, G .
NEUROSCIENCE, 1996, 71 (03) :691-700
[9]   Unexpected Neuroprotective Effects of Loganin on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurotoxicity and Cell Death in Zebrafish [J].
Yao, Li ;
Peng, Shi-Xiao ;
Xu, Yi-Da ;
Lin, Stanley Li ;
Li, Yu-Hong ;
Liu, Chun-Jie ;
Zhao, Hou-De ;
Wang, Lin-Fang ;
Shen, Yan-Qin .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (03) :615-628
[10]   Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice [J].
Acuna-Castroviejo, Dario ;
Tapias, Victor ;
Lopez, Luis C. ;
Doerrier, Carolina ;
Camacho, Encarnacion ;
Carrion, Maria D. ;
Mora, Francisco ;
Espinosa, Antonio ;
Escames, Germaine .
BRAIN RESEARCH BULLETIN, 2011, 85 (3-4) :133-140